RCC LINKING SCIENCE TO PROGRESS Trademark

Trademark Overview

On Monday, November 8, 2004, a trademark application was filed for RCC LINKING SCIENCE TO PROGRESS with the United States Patent and Trademark Office. The USPTO has given the RCC LINKING SCIENCE TO PROGRESS trademark a serial number of 79007930. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, November 8, 2014. This trademark is owned by RCC Ltd.. The RCC LINKING SCIENCE TO PROGRESS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical drugs, not including dietary supplements, and chemical and agricultural products, namely, agrochemical, life science and biocide products for research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products; scientific research for research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products; research of new products for research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products; scientific research, development and analysis for new medicine for humans provided to research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products
rcc linking science to progress

General Information

Serial Number79007930
Word MarkRCC LINKING SCIENCE TO PROGRESS
Filing DateMonday, November 8, 2004
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, November 8, 2014
Registration Number3202252
Registration DateTuesday, January 23, 2007
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 7, 2006

Trademark Statements

Goods and ServicesDevelopment of pharmaceutical drugs, not including dietary supplements, and chemical and agricultural products, namely, agrochemical, life science and biocide products for research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products; scientific research for research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products; research of new products for research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products; scientific research, development and analysis for new medicine for humans provided to research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 6, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRCC Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameRCC Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameRCC Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Friday, July 10, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, June 4, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, June 4, 2015DEATH OF INTERNATIONAL REGISTRATION
Friday, November 14, 2014TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, August 27, 2014GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, August 27, 2014GENERIC MADRID TRANSACTION CREATED
Tuesday, May 6, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 6, 2013CANCELLED SECTION 71
Friday, May 2, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, August 22, 2007FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, August 21, 2007FINAL DISPOSITION PROCESSED
Friday, August 17, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 23, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, November 7, 2006PUBLISHED FOR OPPOSITION
Wednesday, October 18, 2006NOTICE OF PUBLICATION
Tuesday, September 26, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 25, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 20, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 15, 2006ASSIGNED TO LIE
Thursday, September 14, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 24, 2006AMENDMENT FROM APPLICANT ENTERED
Thursday, August 3, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 3, 2006PAPER RECEIVED
Thursday, August 3, 2006NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, July 20, 2006NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, July 20, 2006NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, February 14, 2006NON-FINAL ACTION E-MAILED
Tuesday, February 14, 2006NON-FINAL ACTION WRITTEN
Tuesday, January 24, 2006AMENDMENT FROM APPLICANT ENTERED
Wednesday, December 28, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 28, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 28, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 21, 2005REFUSAL PROCESSED BY IB
Friday, July 1, 2005NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 21, 2005NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 20, 2005NON-FINAL ACTION WRITTEN
Saturday, June 11, 2005ASSIGNED TO EXAMINER
Friday, February 18, 2005NEW APPLICATION ENTERED IN TRAM
Thursday, February 17, 2005SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

progress science linking research products development pharmaceutical field business companies production based medical